GE Healthcare, Bio-Rad Settle on Lawsuit Claiming Patent Infringement of SPR Technology | GenomeWeb
Home » GE Healthcare, Bio-Rad Settle on Lawsuit Claiming Patent Infringement of SPR Technology

GE Healthcare, Bio-Rad Settle on Lawsuit Claiming Patent Infringement of SPR Technology

Aug 15, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare today it has settled with Bio-Rad Laboratories over litigation related to GE Healthcare Life Sciences' technology for studying molecular interactions with surface plasmon resonance.

Financial terms of the settlement were not disclosed. In 2010 GE Healthcare sued Bio-Rad in Germany alleging infringement of SPR-related patents.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Oct 28, 2015

With Clarient Purchase, NeoGenomics Hoping to Offer Most Comprehensive Cancer Genetics Test Menu

Premium
Oct 21, 2015

NeoGenomics to Acquire Clarient From GE

Dec 21, 2015

10X Genomics Founders Prevail in Arbitration Dispute With Bio-Rad

Dec 31, 2015

NeoGenomics Completes Clarient Acquisition

Aug 03, 2016

Bio-Rad Posts 2 Percent Gain in Q2 Revenues

Jan 06, 2016

Enzo Biochem, Agilent Settle Patent Infringement Lawsuit

The Scan

This Week in Nature

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Some Cold Water

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA-Based Wanted Sketch

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

So, What's This Exactly?

Researchers discuss the need for antibody standards at a meeting, NPR reports.

Sponsorships

Privacy Policy.  Copyright © 2016 Genomeweb LLC.  All Rights Reserved.